ArticleHealth affairs scholar2026
Medicare coverage choice is not neutral: how policy design shapes beneficiary enrollment.
Article in Health affairs scholar, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medicare enrollment has shifted substantially toward Medicare Advantage (MA), rising from 33% in 2016 to over half of beneficiaries by 2025. While often interpreted as reflecting beneficiary preference, Medicare coverage choice is not neutral; policy design systematically advantages MA at the point of enrollment. Medicare's choice architecture concentrates salient financial protections and supplemental benefits within MA while deferring the consequences of managed care restrictions as future considerations, when switching options are limited. We identify 3 domains that create structural asymmetries between MA and Traditional Medicare (TM): affordability and benefit offerings, integrated plan design, and information and marketing. Together, these features make MA's advantages more visible at enrollment, through out-of-pocket caps, supplemental benefits, streamlined coverage, and third-party steering, while TM remains comparatively fragmented. We outline policy options to address these imbalances, including introducing an out-of-pocket cap in TM, expanding benefits, simplifying coverage design, improving decision and support tools, and strengthening oversight of marketing and brokerage practices. Leveling the playing field is not about steering beneficiaries toward TM or MA, but about ensuring that Medicare's growing reliance on enrollee choice rests on a foundation of comparability, transparency, and informed decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.